Mandate

Vinge advises First State Investments on acquisition of E.ON Gas Sverige AB.

April 27, 2018 M&A

Vinge has advised European Diversified Infrastructure Fund II ("EDIF II"), an infrastructure fund managed by First State Investments, in connection with the acquisition of E.ON Gas Sverige AB.

E.ON Gas Sverige AB is the part of E.ON Sverige AB which owns gas networks. First State Investments is a global fund manager with more than 20 years of infrastructure investment experience. EDIF II, where investors are predominantly European pension funds, focuses on long-term investments in European infrastructure companies.

The Vinge team advising First State Investments includes Christoffer Thalin together with Kristoffer Franzkeit, Niklas Törnell, Anna Jonson, Anna Thuresson, Henrik Borna, Freja Ljungdell Kristensen, Daniel Melander Björner, Mathias Lindquist, Jack Bengtsson and Emelie Svensäter Jerntorp. Henrik Ossborn and Fredrik Christiansson advised on the financing of the transaction. Björn Mullaart and Rickard Vernet provided competition law advice.


 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025